Attention Readers: It's Monday and our Lead Technical Tactician Nate Bear is giving away his weekly stocks to watch. In today's video, he talks about the FOMC meeting this Wednesday. He also has two stocks he's looking at for potential trades. Click the image below to see Nate's picks. If you want to start trading alongside Nate in real time, he recently launched a new service, Profit Surge Trader. By joining, you'll be able to follow along as Nate trades just ONE TICKER over and over again for maximum potential profits. Click here to learn more about Profit Surge Trader. Good morning Wake-up Watchlisters! While you're sipping coffee you'll see stock futures were steady on Monday after Friday's selloff. A three-week rally in oil prices pushed the benchmark Brent higher by 11%, and that's making it more dicey for central bankers waging war on inflation. Expect investors to be more cautious this week leading up to the FOMC announcement. Oil stocks were the big winners in 2022, and our friend Marc Lichtenfeld has been pounding the table on this alternative investment in the energy sector. It's not a stock, bond, or private company, and it could hand you monthly income over and over… for life. Click here to discover Marc's No. 1 energy play for 2023. Here's a look at the top-moving stocks this morning. Iovance Biotherapeutics (Nasdaq: IOVA) Iovance Biotherapeutics is up 7.97% premarket. The company's independent director Wayne Rothbaum announced he bought 28% more shares. Rothbaum spent $27 million on stock at an average price of $5.30 a share. The recent purchase was the biggest insider buy for the pharmaceutical company this year. |
Post a Comment
Post a Comment